RE: Where is the anticipatory buying?31 Jul 2024 17:27
Cobaltblue, we will soon find out when the data results come out. In your head, with your holding, you expect nothing spectacular from the data, as you assume, this company is a waste, and the molecule 1801 will be a flop. Fits your criteria, needed to deride it, so can make a few pennies on shorting it.
Anyone genuinely invested here, imagine the reaction of the market to great data results. That will speak, as will indicate how quick money can be bought in for next stage, as if good , it is derisked and then it is worth it.
Big pharmaceutical always have to take a gamble, nothing is guaranteed till it goes into patients . How many big deals done on licence have gone wrong, big money spent, and a waste but it is worth the risk to these companies, to get the next golden egg